NDA readiness MacroStat specializes in integrated summaries of efficacy and safety for new drug applications and NDA submissions, indicating strong engagement with regulatory-compliant data services and opportunities to offer end-to-end submission support, consulting on regulatory strategy, and expansion into additional markets.

Clinical data capabilities With services spanning protocol development, sample size calculations, data management, SDTM/ADaM, SAS programming, and DSMB support, there are multiple cross-sell opportunities to existing pharma and biotech clients needing comprehensive data management and statistical analysis pipelines.

Growing mid-market The company size (50–200 employees) and revenue range ($100M–$250M) position MacroStat as a mid-sized partner capable of scaling engagements for medium to large clinical programs, suggesting upsell potential to larger CRO-like projects and long-term data management contracts.

Global regulatory exposure Providing NDA submissions to regulatory agencies worldwide signals familiarity with multiple jurisdictions, enabling a sales approach that highlights international regulatory readiness, harmonization services, and potential collaboration for global trial support and dossier publishing.

Tech-enabled services A diverse tech stack including cloud providers, DNS/CDN services, and collaboration suites points to readiness for cloud-based data management, secure data transfer, and scalable analytics workloads, opening doors for modern data platforms, SaaS enhancements, and process automation collaborations.